ELDEPRYL

Welcome to the Brand page for “ELDEPRYL”, which is offered here for In the statement, column 2, line 1, nerological should be deleted, and neurological should be inserted.;pharmaceutical preparation for the treatment of a wide variety of diseases and disorders, such as, parkinson's disease and [ nerological ] * neurological * disorders;.

Its status is currently believed to be active. Its class is unavailable. “ELDEPRYL” is believed to be currently owned by “SOMERSET PHARMACEUTICALS, INC.”

Owner:
SOMERSET PHARMACEUTICALS, INC.
Owner Details
Description:
IN THE STATEMENT, COLUMN 2, LINE 1, NEROLOGICAL SHOULD BE DELETED, AND NEUROLOGICAL SHOULD BE INSERTED.;PHARMACEUTICAL PREPARATION FOR THE TREATMENT OF A WIDE VARIETY OF DISEASES AND DISORDERS, SUCH AS, PARKINSON'S DISEASE AND [ NEROLOGICAL ] * NEUROLOGICAL * DISORDERS;
Categories: STATEMENT